找不到产品?留下需求帮您找
一键询价梅里埃 10400奈瑟氏球菌嗜血菌鉴定盒API NH
两周
面议
梅里埃 API氧化酶试剂
两周
面议
CCFSTTG1 人脑星形细胞瘤 QCH828
一周
3500¥
MM28 人眼葡萄膜黑色瘤細胞 QCH829
一周
5500¥
HCC202 人乳腺原发性导管癌 QCH830
一周
3000¥
HCC2157 人乳腺导管癌细胞(三阴性)QCH831
一周
5000¥
hCMEC/D3-RFP红色荧光蛋白标记的人脑微血管内皮细胞 QCH346R
一周
3500¥
KHYG-1 人NK细胞淋巴瘤细胞 QCH833
一周
3500¥
NCI-h1869 人非小细胞肺癌鳞癌细胞 QCH834
一周
3500¥
NCI-H1417 人小细胞肺癌细胞 QCH835
钦诚生物 | 一周
3500¥
其他参数
HAT培养基添加剂 (50×)
HAT Supplement (50×)
产品规格:10ml
保存条件: Store at -20℃.
产品介绍:
HAT Supplement is a liquid mixture of sodium hypoxanthine, aminopterin and thymidine. After dilution, HAT is suitable for use as a post-fusion selective medium to eliminate unfused or self-fused HGPRT-myeloma cells.
γ-irradiated, lyophilized powder, BioXtra, suitable for hybridoma;
Application:
HAT Media Supplement (50×) Hybri-Max has been used:
in the selection and validation of hypoxanthine-guanine phosophoribosyltransferase (HPRT)-deficient clones.
in the generation of mAbs (monoclonal antibodies).
in the luciferase-based bioassay (LUC) assay.
Reconstitution:
Reconstitute contents of vial with 10 ml sterile cell culture medium. Stock solution is sufficient to prepare 500 ml medium. Final working concentration: 100 μM hypoxanthine, 0.4 μM aminopterin, 16 μM thymidine.
特别提示:本公司的所有产品仅可用于科研实验,严禁用于临床医疗及其他非科研用途!